This agrees with reports indicating the high expression of the CDKN1B gene in androgen-dependent prostate cancer cells and a lack of its significance in the case of androgen-independent cells, such as PC-3 cells [40]. This evidence concerns the gene CDKN1B and prostate carcinoma.